Infinity Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme …

Biotechnology
US, Cambridge [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of INFI's Analysis
CIK: 1113148 CUSIP: 45665G303 ISIN: US45665G3039 LEI: - UEI: -
Secondary Listings
INFI has no secondary listings inside our databases.